微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 53.32% | -9.83% | 0.89% | 66/132 | 51.53% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 52.85% | -13.19% | -3.37% | 66/132 | 51.65% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 54.7% | -11.13% | -1.47% | 63/132 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 55.51% | 0.15% | -6.12% | 63/132 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 59.13% | -1.03% | -2.88% | 57/132 | 53.25% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 60.88% | 4.94% | -1.09% | 55/132 | 53.3% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 61.55% | 10.09% | 11.04% | 50/132 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 55.43% | 3.45% | -7.23% | 66/132 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 59.75% | 8.04% | 2.99% | 55/132 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 58.02% | 1.94% | 3.77% | 60/132 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 55.91% | 2% | 4.35% | 63/132 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 53.58% | -19.36% | -3.12% | 68/132 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 55.3% | -27.86% | -2.83% | 67/132 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 56.91% | 2% | -14.34% | 66/132 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 66.44% | -11.04% | -11.04% | 47/132 | 57.29% | 三友医疗 | 90.73% | 行业排名> |
| 2020-12-31 | 74.69% | 2% | -2.57% | 30/132 | 59.59% | 三友医疗 | 90.5% | 行业排名> |
| 2020-09-30 | 76.66% | 2% | 2% | 22/132 | 61.59% | 三友医疗 | 90.29% | 行业排名> |